Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment

NCT00935831 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Disease

Interventions

DRUG: GSK1278863A
DRUG: Placebo

Sponsor

GlaxoSmithKline